[Glucagon-releasing activity of xenopsin, neurotensin and substance P in the perfused rat pancreas (author's transl)]. 1978

R Tanaka, and K Shima, and Y Kumahara, and T Matsuyama, and S Tarui, and N Sawazaki

It has been reported that Xenopsin, Neurotensin and Substance P change plasma glucagon and insulin levels when they are administered in vivo. In order to clarify whether these agents have a direct effect on glucagon and insulin secretion from the pancreas, the action of each substance was examined by using the rat pancreas perfusion technique. The results were as follows: The perfusion with 1 and 5 nmole/min of Xenopsin for ten minutes resulted in a significant but transient release within two minutes. Neurotensin did not show any stimulatory effect on glucagon release in the concentration of 1 or 5 nmole/min for ten minutes. However, Substance P lowered significantly the glucagon concentration in the perfusate in a similar concentration. None of these substances influenced significantly insulin release from the perfused pancreas. These findings suggest that the hyperglucagonemia caused by these three agents in vivo may not be attributed to the direct effect on the pancreatic A-cell.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008297 Male Males
D009496 Neurotensin A biologically active tridecapeptide isolated from the hypothalamus. It has been shown to induce hypotension in the rat, to stimulate contraction of guinea pig ileum and rat uterus, and to cause relaxation of rat duodenum. There is also evidence that it acts as both a peripheral and a central nervous system neurotransmitter.
D009842 Oligopeptides Peptides composed of between two and twelve amino acids. Oligopeptide
D010179 Pancreas A nodular organ in the ABDOMEN that contains a mixture of ENDOCRINE GLANDS and EXOCRINE GLANDS. The small endocrine portion consists of the ISLETS OF LANGERHANS secreting a number of hormones into the blood stream. The large exocrine portion (EXOCRINE PANCREAS) is a compound acinar gland that secretes several digestive enzymes into the pancreatic ductal system that empties into the DUODENUM.
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D010477 Perfusion Treatment process involving the injection of fluid into an organ or tissue. Perfusions
D005934 Glucagon A 29-amino acid pancreatic peptide derived from proglucagon which is also the precursor of intestinal GLUCAGON-LIKE PEPTIDES. Glucagon is secreted by PANCREATIC ALPHA CELLS and plays an important role in regulation of BLOOD GLUCOSE concentration, ketone metabolism, and several other biochemical and physiological processes. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1511) Glucagon (1-29),Glukagon,HG-Factor,Hyperglycemic-Glycogenolytic Factor,Proglucagon (33-61),HG Factor,Hyperglycemic Glycogenolytic Factor
D000078790 Insulin Secretion Production and release of insulin from PANCREATIC BETA CELLS that primarily occurs in response to elevated BLOOD GLUCOSE levels. Secretion, Insulin
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

R Tanaka, and K Shima, and Y Kumahara, and T Matsuyama, and S Tarui, and N Sawazaki
November 1976, Metabolism: clinical and experimental,
R Tanaka, and K Shima, and Y Kumahara, and T Matsuyama, and S Tarui, and N Sawazaki
May 1979, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
R Tanaka, and K Shima, and Y Kumahara, and T Matsuyama, and S Tarui, and N Sawazaki
June 1973, The Biochemical journal,
R Tanaka, and K Shima, and Y Kumahara, and T Matsuyama, and S Tarui, and N Sawazaki
January 1978, Nihon rinsho. Japanese journal of clinical medicine,
R Tanaka, and K Shima, and Y Kumahara, and T Matsuyama, and S Tarui, and N Sawazaki
September 1982, Life sciences,
R Tanaka, and K Shima, and Y Kumahara, and T Matsuyama, and S Tarui, and N Sawazaki
November 1976, Metabolism: clinical and experimental,
R Tanaka, and K Shima, and Y Kumahara, and T Matsuyama, and S Tarui, and N Sawazaki
January 1976, Acta biologica et medica Germanica,
R Tanaka, and K Shima, and Y Kumahara, and T Matsuyama, and S Tarui, and N Sawazaki
January 1982, Recent progress in hormone research,
R Tanaka, and K Shima, and Y Kumahara, and T Matsuyama, and S Tarui, and N Sawazaki
January 1986, Methods in enzymology,
R Tanaka, and K Shima, and Y Kumahara, and T Matsuyama, and S Tarui, and N Sawazaki
April 1990, Japanese journal of pharmacology,
Copied contents to your clipboard!